Guatemala is the largest economy in Central America and one of the first markets US device companies ask me about after Mexico and Colombia. The question I hear most is “how fast is MSPAS?” The question that decides whether the launch goes well is different: whose Guatemalan license and whose power of representation sit on the file.
I am Julio Martinez-Clark, CEO of bioaccess®. This page is the commercial Guatemala file: how a medical device that is already FDA-cleared or CE-marked gets a Certificado de Inscripción Sanitaria from the Ministerio de Salud Pública y Asistencia Social (MSPAS), what goes in the dossier, and how to keep control of it. It sits next to our LATAM market-access hub, the Guatemala MSPAS country page and the Importer of Record guide. Operator guidance only. Not a quote and not legal advice.
One-sentence answer
To import and sell a medical device in Guatemala you need a Certificado de Inscripción Sanitaria issued by MSPAS through the Sección de Autorizaciones Sanitarias de Productos Afines of the Departamento de Regulación y Control de Productos Farmacéuticos y Afines (DRCPFA), filed on form F-AS-f-08 through a Guatemalan distributor or droguería with a current Licencia Sanitaria, under Acuerdo Gubernativo 712-99 and the device technical standard Norma Técnica 37.
The legal stack
Guatemala regulates devices as “productos afines” rather than under a stand-alone device law. The base regulation is Acuerdo Gubernativo 712-99 of 17 September 1999, the Reglamento para el Control Sanitario de los Medicamentos y Productos Afines, amended over the years, including by Acuerdo Gubernativo 351-2006 and Acuerdo Gubernativo 104-2018. The operating detail for devices sits in Norma Técnica 37, version 5-2016, on the sanitary registration of medical devices.
The DRCPFA publishes the current legislation and technical standards on the MSPAS medicines portal. MSPAS also notes that requirements can change with updates to technical standards, Central American technical regulations and forms. Treat any checklist, including this one, as a starting point to confirm against the current F-AS-f-08 version before you file.
What the certificate does
The Certificado de Inscripción Sanitaria is the document MSPAS issues to state that a device meets the current technical standards so it can be imported and sold in Guatemala. It is a commercial authorization. It does not cover study units for a first-in-human or other clinical investigation, which follow the research and ethics track described on our Guatemala clinical trials page.
What goes in a new registration
For a new inscription, or a renewal with a change, the MSPAS procedure lists the following:
- Proof of payment of the inscription fee.
- Form F-AS-f-08, signed, sealed and stamped by the Guatemalan responsible professional.
- Finished-product specifications on the manufacturer’s letterhead, signed by the manufacturer’s responsible professional.
- Primary and/or secondary packaging artwork.
- The manufacturer’s quality-control certificate for the product.
- A manufacturing-guarantee certificate issued by the health authority: GMP, standards approval, ISO 9001, FDA or equivalent.
- For foreign products, a certificate of free sale from the country of origin.
- A product description in Spanish.
- An authenticated copy of the manufacturer’s power of representation.
- Sealed samples, when applicable.
- Technical literature, catalog or insert in Spanish, when applicable.
- A copy of the file for the Laboratorio Nacional de Salud (LNS).
- A current Licencia Sanitaria for the principal distributor or droguería and for any additional distributors.
Two rules trip up US teams. Documents issued abroad have to meet Guatemala’s legalization requirements, which in practice means apostille for Hague countries. Anything not in Spanish has to be translated by a sworn translator authorized in Guatemala, under Article 37 of the Ley del Organismo Judicial. A translation done in the US and notarized there is not the same thing.
Renewals without changes are lighter: payment, a new F-AS-f-08, a letter from the legal representative and the responsible professional confirming the original or approved conditions still hold, and current distributor licenses.
Where control of the registration lives
Read item 9 and item 13 together. The manufacturer’s power of representation names who speaks for you in front of MSPAS. The distributor’s Licencia Sanitaria is what lets that company import. In Guatemala the file runs through a principal distributor or droguería, with additional licensed distributors possible. That puts the commercial decision in the power of attorney and the distribution agreement, not in the regulatory form.
The pattern I see across Central America is the same. When a distributor offers to fund the filing, it usually ends up controlling the certificate and the import channel, and it can slow down any change when the relationship ends. Changing who holds a Guatemalan registration later is a formal procedure with MSPAS, not a letter. The cheaper path is to decide at the start who pays, whose power of representation is on file, and what the agreement says about transfer on demand.
Timelines
I do not publish a statutory day-count for Guatemala. Review time depends on the dossier, the product type and MSPAS workload. Build the plan around three clocks you control: apostille and sworn translation, the distributor’s license status, and how quickly your team answers observations. Confirm the current review window with MSPAS when you set a launch date.
What this file is not
- It is not a clinical-trial approval. Study units and commercial units follow different files.
- It is not part of the bioaccess® fixed-price market-access subscription. That subscription runs in multi-importer model countries plus Argentina. Guatemala is quoted case by case.
- It is not a translation shortcut. US-notarized translations do not replace a Guatemalan sworn translator.
How bioaccess® runs Guatemala registrations
On the live offer, bioaccess® processes Guatemala registrations funded by the manufacturer: dossier preparation against Norma Técnica 37, coordination of apostille and sworn Spanish translation, agency liaison through approval, and tecnovigilancia support. Your distributor holds the Licencia Sanitaria and imports, while the distribution agreement, reviewed by local counsel, keeps transfer-on-demand terms with you. MSPAS fees are set by the regulator and scoped pricing is confirmed at proposal. See bioaccessla.com/market-access/guatemala-mspas.
Operator checklist before you open a Guatemala folder
- Confirm the distributor or droguería has a current MSPAS Licencia Sanitaria and a responsible professional who will sign F-AS-f-08.
- Decide who funds the filing and whose power of representation goes on file before you sign distribution terms.
- Start apostille on the free-sale, GMP or ISO and power-of-attorney documents early. Those are the long poles.
- Book a Guatemalan sworn translator for the description, labels and IFU.
- Check the current F-AS-f-08 version and Norma Técnica 37 requirements on the MSPAS portal.
- Run RF or telecom homologation for wireless devices as a separate track.
- Keep trial and commercial files on separate pages with separate owners.
Talk with bioaccess® when you want a Guatemala registration filed on your terms instead of your first distributor’s.